Vaccination against foot-and-mouth disease and brucellosis begins in Colombia

Published Nov 4, 2022

Tridge summary

Colombia has initiated its second cycle of vaccination against foot-and-mouth disease and bovine brucellosis, aiming to maintain its disease-free certification granted in February 2020 by the World Organization for Animal Health. The vaccination, which will be applied to 30 million animals across 619,637 farms, is a collaborative effort between the ICA and the Colombian Federation of Livestock Farmers (FEDEGÁN-FNG). The campaign, which runs from November 8 to December 22, 2022, is crucial for maintaining health security, eradicating foot-and-mouth disease, and allowing international trade. Farmers are encouraged to ensure all animals are vaccinated.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The main purpose of the cycle is to maintain the status of the country, that is, the certification of being free of foot-and-mouth disease with vaccination, granted since February 2020 by the highest global health authority, the World Organization for Animal Health, WHOA. As of this Tuesday, November 8, the execution of the second cycle of vaccination against foot-and-mouth disease and bovine brucellosis begins, ordered by Resolution No. 00019823 of October 10, 2022, it will be applied for 45 days and will last until the 22 December 2022, said the general manager of the ICA, Deyanira Barrero León. According to José De Silvestri, technical manager of FEDEGÁN-FNG and technical leader of the cycle at the national level, 619,637 farms dedicated to livestock production will be visited, in which 30 million animals (30,027,896 heads) will be vaccinated. This last figure is distributed as follows: cattle 29.5 million and buffalo 486,000. 1.6 million (1,637,737 calves) will also be ...
Source: MXContexto

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.